WOW. Its a wow factor...

Bijak 8dragon. Orang yang tidak bijak kutip saham sampah pun dah dapat untung. Aeak dalam forum ni semata-mata hendak degraded orang lain yang percaya pada saham nexgram. Mesti awak ada agenda tersendiri. Bijak. Awak memang bijak.

Lack of publicities in media from management compared to certain companies such as AT and HWGB.

As we know, Nexgram only involves in trading of some sorts of Covid-19 goods. Not to be a producer of the goods such as certain company.

From other forum discussions, I never noticed that Nexgram listed as the one of the company which involves in gloves business or linked to healthcare business .

I am standing by you Cuwawa. Thanks for the info.

Inix just has 325,224,750 shares issued

The latest issue of shares is 2,361,204,480

Not so many players believe in this stock. Without sharks and punters, the stock cann't fly, especially the quantity of the shares is huge. I hope there are operators in progress to push the stock price.

@8dragon. Just for gottogo. I think one of the rason why the price of this stock up from 0.005 until 0.08 becouse of Nexgram involvement in healthcare business.

@TTD1990. The history of old management of the company was bad. As for me, the new management especially Tn. Hj Mazru is more reliable and convincing.

https://nexgram.co/

Nexgram Medical (NMed) specialize in business advisory in procurement and distribution of medical devices such as Antibody & Antigen Rapid Test Kit, PCR Reagents Test Kit, and other molecular diagnosis solutions.

NMed also held master distributorship for Ventilator, Hospital devices, Thermometer with Face recognition & Disinfection spraying system, as well as personal protective equipment (PPE) such as 3-ply masks, N95 face masks, KN90 face masks, Surgical masks, Medical protective glasses, Disposable Surgical Medical Gown & Clothing, Sanitizer, as well as referrals to authorities approved Vaccines and Medicine supplies.

Nexgram Medical is available to International markets such as Thailand, Malaysia, Indonesia, Vietnam, Cambodia, India, France, Spain, Germany, South Africa, and other countries and regions.

NMed is operated by Tri-G Technologies Sdn Bhd, together with sister company Nexgram Biomedic Sdn Bhd, both subsidiaries of Nexgram Industries, part of Nexgram Holdings Berhad.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045242

EXCLUSIVE MASTER DISTRIBUTION AGREEMENT ENTERED INTO BY TRI-G TECHNOLOGIES SDN BHD (TRI-G) FOR DISTRIBUTING TRI-G'S COVID-19 MEDICAL DEVICES TO BE UNDERTAKEN BY NEXGRAM INDUSTRIES SDN BHD
Reference is made to the Company’s announcement dated 20 April 2020 in relation to the Strategic Outsourcing Agreement, it was stated therein that Nexgram Industries Sdn. Bhd. (“NISB”), the wholly-owned subsidiary of the Company had on 27 March 2020 appointed as the Exclusive Master Distributor of Tri-G Technologies Sdn. Bhd. (“TRI-G”) to distribute TRI-G’s medical supplies, including quantitative RT-PCR (Reverse Transcription Polymerase Chain Reaction) or RT-qPCR (Quantitative Reverse Transcription PCR) machines, reagents and test kits and Coronavirus test kits in Malaysia for a period of 2 years, commencing 27 March 2020.



In furtherance to that, the Board of Directors of Nexgram wishes to clarify and announce further information in relation to the Exclusive Master Distribution Agreement ("DA") entered into between TRI-G and NISB.



Please refer to the attachment for details of the announcement.



This announcement is dated 21 April 2020.

Earlier

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045166

STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET
The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 16 April 2020 entered into a Strategic Sourcing Agreement (“Agreement”) with PT Mitra Abadi Propertindo Utama (“MAPU”) to sell to MAPU for the latter to promote, market and distribute Detection and Diagnostic Kit and Rapid Test Kit, and other medical supplies products in Indonesia and certain part of South East Asia market, as per the terms and condition of the Agreement.



Please refer to the attachment for details of the announcement.



This announcement is dated 20 April 2020.

Earlier,

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045665

STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT RAFA TOPAZ UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO JAKARTA TIMUR INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET
The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 21 April 2020 entered into a Strategic Sourcing Agreement (“Agreement”) with PT Rafa Topaz Utama (“RAFA”) to sell to RAFA for the latter to promote, market and distribute medical ventilators in Jakarta Timur, Indonesia and certain part of South East Asia market, as per the terms and condition of the Agreement.



Please refer to the attachment for details of the announcement.



This announcement is dated 22 April 2020.

@gotogo.
Earlier, Nexgram's subsidiary, NISB also involves for distributing TRI-G'S COVID-19 MEDICAL DEVICES and as an authorised distributor for Malaysia. Its also involves Indonesia's market.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3053418

The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 12 March 2020 entered into a Sales Agreement (“Agreement”) with Shanghai Liangrun Biomedicine Technology Co., Ltd (“Shanghai Liangrun”) to sell their product, Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 (“Diagnostic Kit”) in Malaysia and Indonesia. Besides, Shanghai Liangrun has directly appointed NISB as the authorised distributor to seek the approvals from the Ministry of Health in Malaysia and relevant authorities in Indonesia for the distribution of the Diagnostic Kit.



Please refer to the attachment for details of the announcement.



This announcement is dated 27 May 2020.

@gotogo. Exporting masks is prohibited.
Instead, Nexgram will be exporting PPE- (gowns and medical Gloves) as stated below:

CONDITIONAL OFFTAKE AND PURCHASE AGREEMENT
ENTERED INTO BETWEEN NEXGRAM BIOMEDIC SDN BHD
WITH PT MITRA ABADI PROPERTINDO UTAMA FOR
DISTRIBUTING PERSONAL PROTECTION EQUIPMENT TO
INDONESIA

The Company’s announcement dated 23 July 2020 (“Announcement”) and the query letter
from Bursa Malaysia Securities Berhad dated 27 July 2020 (Ref : IQL-27072020-00002) in
relation to the Conditional Offtake and Purchase Agreement (“Agreement”) refer. Unless
otherwise stated, the terms used in this announcement shall have the same meaning as
defined in the Announcement.
The Board of Directors of Nexgram wishes to announce the following additional information
as required in Query:
1. The source of the supply of the PPE i.e. the gown and medical gloves to NBSB
for NBSB’s onward distribution to MAPU.
NBSB get the supply from Crecom Burj Gloves Sdn Bhd which NBSB is the appointed
representative for AAMI Isolation Gown and K-Gloves Nitrile Examination.
2. Total capital and/or investment outlay required of NEXGRAM and/or NBSB in
respect of the venture into the distribution of PPE to MAPU.
No capital or investment outlay is required by NBSB as the customer is required to pay
the deposit of their order.
3. Clarification on whether the sale of PPE to MAPU requires any government
approvals in Malaysia and/or Indonesia. If yes, please state the government
approvals NBSB needs to obtain and the status of such approvals.
PPE is not required approval from Medical Device Authority. However, MAPU will apply
the special access approval from Kementerian Kesehatan Republik Indonesia upon
each delivery.
4. The commencement and expiry dates of the sale of the Products to MAPU as
stipulated in the Agreement.
The first delivery of the order for AAMI Isolation Gown and K-Gloves Nitrile
Examination Gloves-Powder Free will be on November 2020.
This announcement is dated 28 July 2020

Sampah pun sekarang ada nilainya. Ada orang cari makan dengan sampah. Dapat untung lebih dari 100% lagi. HaHa

RM0.1 mesti kena pecah. Lepas tu tengok lah

Harapa ini kli lah

Sorry other than gloves and ppe

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3053389

Other than gloves and masks.

Setuju dengan cuwawa. Sekadar kemungkinan. Tengok spike harga dan volume hari tu

Harap-harap dah clear tranche pertama,

Untuk yang Ozura dispose 5,6 dan 7 ogos tak perlu diannounce dah. Saya rasa pada hari-hari itu juga Ozura ada dispose.

There is no permission needed for investors to invest in particular stocks. HeHe

Agreed. Nexgram under accumulation.

Jumlah hutang asalnya ialah RM12,543,793.94

Itulah niubee126. Ozura dapat hak ICPS tersebut amat menguntungkan kerana pada masa penetapan pemberiaan hak ICPS kepada Ozura dari hutangnya kepada Nexgram, harga Nexgram pada masa itu sangat rendah.

Investor can wait, OKU_2020.

Thats why. I think the main problem for Nexgram now is the ICPS fiasco. If not, I think easily its can shoot up...Just two cents thought.

133,500 000 units left is...

133,500,000 units if from the first trance of subscription.

eins. If I,m not wrong there is 337,189,697 units of ICPS which not subscribed yet

Hello. wiwiwik. Kelakarnya

Saya rasa, operator akan kontrol harga sekarang sehingga Ozura habis keluar tranche pertama ICPS. Tuhan saja yang tahu.

Walau macam mana pun saya positif dengan Nexgram. Akan tunggu dengan sedikit saham yang ada.

Betul Askhalan. Tapi kalau dia betul-betul ingin convert dari creditor kepada pelabur. Ozura tidak akan jual saham dan join Nexgram untuk bentuk sinergy bagi Nexgram dan Ozura juga.

Rasanya Ozura cash out untuk dapat capital bagi subscribe baki ICPS yang masih banyak tidak disubscribe. Pada saya, prospek Nexgram sekarang lebih baik dari dua tahun lepas dengan perkembangan terbaru syarikat. Bagi saya positif.

Ozura bukan pelabur dalam Nexgram. Ozura adalah creditor

Nampak macam operator kontrol harga 6-6.5 sen untuk exit bagi Ozura.

Kena tunggu sajalah. Harap-harap QR sept nanti positif.

Operator lain pun belum berani push harga. Halangan ICPS cukup besar.

Ozura control nak jual 6.5 sen. Asyik tambah que selling qty +- 350k lot. Well planned. Jual 6.5 sen modal 1+2 sen...

ikut rasa saya, Nexgram dalam fasa accumulation. Setuju dengan cuwawa

Minat terhadap saham Nexgram terkini menunjukkan trend menaik. Cuma adakah ia fasa accumulation atau fasa distribution?

Hold

OKU_2020 is the agent of Nexgram's investors. He.he

its up to you OKU_2020. The fact should be the fact.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=2265486

OKU_2020. Revised Exercise/Strike/Conversion Price for Nexgram WB RM0.2600